search results for 
Logo

Fresenius SE & Co. KGaA
Consolidated statement of changes in equity


    Ordinary shares Preference shares Subscribed Capital Reserves        
  Note Number of shares in thousand Amount € in thousands Number of shares in thousand Amount € in thousands Amount € in thousands Amount € in millions Capital reserve € in millions Other reserves € in millions Accumulated other comprehensive income (loss) € in millions Total Fresenius SE & Co. KGaA shareholders’ equity
€ in millions
Noncontrolling interest not subject to put provisions € in millions Total shareholders’ equity € in millions
The following notes are an integral part of the consolidated financial statements.
As of December 31, 2010   81,225 81,225 81,225 81,225 162,450 162 2,085 2,683 35 4,965 3,879 8,844
Conversion of the preference shares into ordinary shares 1 81,225 81,225 -81,225 -81,225 0 0       0 0 0
Proceeds from the exercise of stock options 35 787 787 0 0 787 1 51     52 47 99
Compensation expense related to stock options 35             20     20 15 35
Dividends paid 28               -140   -140 -192 -332
Purchase of noncontrolling interest not subject to put provisions 27                   0 42 42
Maturity of Mandatory Exchangeable Bonds 24               467   467 298 765
Purchase of ordinary shares of Fresenius Medical Care AG & Co. KGaA 2, 27               -42   -42 -28 -70
Change in fair value of noncontrolling interest subject to put provisions 27             -20     -20 -47 -67
Comprehensive income (loss)                          
Net income                 690   690 605 1,295
Other comprehensive income (loss)                          
Cash flow hedges 29, 31                 -21 -21 -33 -54
Change of fair value of available for sale financial assets 29, 31                 -8 -8 - -8
Foreign currency translation 29, 31                 22 22 47 69
Actuarial losses on defined benefit pension plans 26, 29                 -14 -14 -27 -41
Comprehensive income                 690 -21 669 592 1,261
As of December 31, 2011   163,237 163,237 0 0 163,237 163 2,136 3,658 14 5,971 4,606 10,577
Issuance of bearer ordinary shares 28 13,800 13,800 0 0 13,800 14 989     1,003 0 1,003
Proceeds from the exercise of stock options 35 1,151 1,151 0 0 1,151 1 74     75 65 140
Compensation expense related to stock options 35             22     22 14 36
Dividends paid 28               -155   -155 -204 -359
Purchase of noncontrolling interest not subject to put provisions 27                   0 56 56
Purchase of ordinary shares of Fresenius Medical Care AG & Co. KGaA 2, 27               -71   -71 -43 -114
Change in fair value of noncontrolling interest subject to put provisions 27             4     4 10 14
Comprehensive income (loss)                          
Net income                 926   926 734 1,660
Other comprehensive income (loss)                          
Cash flow hedges 29, 31                 23 23 -1 22
Change of fair value of available for sale financial assets 29, 31                 -9 -9 - -9
Foreign currency translation 29, 31                 -80 -80 -76 -156
Actuarial losses on defined benefit pension plans 26, 29                 -76 -76 -36 -112
Comprehensive income (loss)                 926 -142 784 621 1,405
As of December 31, 2012   178,188 178,188 0 0 178,188 178 3,225 4,358 -128 7,633 5,125 12,758

    Ordinary shares Preference shares Subscribed Capital Reserves        
  Note Number of shares in thousand Amount € in thousands Number of shares in thousand Amount € in thousands Amount € in thousands Amount € in millions Capital reserve € in millions Other reserves € in millions Accumulated other comprehensive income (loss) € in millions Total Fresenius SE & Co. KGaA shareholders’ equity
€ in millions
Noncontrolling interest not subject to put provisions € in millions Total shareholders’ equity € in millions
The following notes are an integral part of the consolidated financial statements.
As of December 31, 2010   81,225 81,225 81,225 81,225 162,450 162 2,085 2,683 35 4,965 3,879 8,844
Conversion of the preference shares into ordinary shares 1 81,225 81,225 -81,225 -81,225 0 0       0 0 0
Proceeds from the exercise of stock options 35 787 787 0 0 787 1 51     52 47 99
Compensation expense related to stock options 35             20     20 15 35
Dividends paid 28               -140   -140 -192 -332
Purchase of noncontrolling interest not subject to put provisions 27                   0 42 42
Maturity of Mandatory Exchangeable Bonds 24               467   467 298 765
Purchase of ordinary shares of Fresenius Medical Care AG & Co. KGaA 2, 27               -42   -42 -28 -70
Change in fair value of noncontrolling interest subject to put provisions 27             -20     -20 -47 -67
Comprehensive income (loss)                          
Net income                 690   690 605 1,295
Other comprehensive income (loss)                          
Cash flow hedges 29, 31                 -21 -21 -33 -54
Change of fair value of available for sale financial assets 29, 31                 -8 -8 - -8
Foreign currency translation 29, 31                 22 22 47 69
Actuarial losses on defined benefit pension plans 26, 29                 -14 -14 -27 -41
Comprehensive income                 690 -21 669 592 1,261
As of December 31, 2011   163,237 163,237 0 0 163,237 163 2,136 3,658 14 5,971 4,606 10,577
Issuance of bearer ordinary shares 28 13,800 13,800 0 0 13,800 14 989     1,003 0 1,003
Proceeds from the exercise of stock options 35 1,151 1,151 0 0 1,151 1 74     75 65 140
Compensation expense related to stock options 35             22     22 14 36
Dividends paid 28               -155   -155 -204 -359
Purchase of noncontrolling interest not subject to put provisions 27                   0 56 56
Purchase of ordinary shares of Fresenius Medical Care AG & Co. KGaA 2, 27               -71   -71 -43 -114
Change in fair value of noncontrolling interest subject to put provisions 27             4     4 10 14
Comprehensive income (loss)                          
Net income                 926   926 734 1,660
Other comprehensive income (loss)                          
Cash flow hedges 29, 31                 23 23 -1 22
Change of fair value of available for sale financial assets 29, 31                 -9 -9 - -9
Foreign currency translation 29, 31                 -80 -80 -76 -156
Actuarial losses on defined benefit pension plans 26, 29                 -76 -76 -36 -112
Comprehensive income (loss)                 926 -142 784 621 1,405
As of December 31, 2012   178,188 178,188 0 0 178,188 178 3,225 4,358 -128 7,633 5,125 12,758

Continue reading:
Consolidated segment reporting